BACKGROUND AND OBJECTIVE: Infant formula is supplemented with long-chain polyunsaturated fatty acids (LCPUFAs) because they are hypothesized to improve cognition. Several randomized controlled clinical trials have examined the effect of LCPUFA supplementation of infant formula on cognitive development. We conducted this meta-analysis to examine the efficacy of LCPUFA supplementation of infant formula on early cognitive development. METHODS: Two authors searched PubMed, PsychInfo, and Scopus for randomized controlled clinical trials assessing the efficacy of LCPUFA supplementation of infant formulas on cognition. Our analysis was restricted to randomized controlled clinical trials that examined the effect of LCPUFA supplementation on infant cognition using Bayley Scales of Infant Development. Our primary outcome was the weighted mean difference in Bayley Scales of Infant Development score between infants fed formula supplemented with LCPUFA compared with unsupplemented formula. We conducted secondary subgroup analyses and meta-regression to examine the effects of study sample, LCPUFA dose, and trial methodologic quality on measured efficacy of supplementation. RESULTS: Twelve trials involving 1802 infants met our inclusion criteria. Our meta-analysis demonstrated no significant effect of LCPUFA supplementation of formula on infant cognition. There was no significant heterogeneity or publication bias between trials. Secondary analysis failed to show any significant effect of LCPUFA dosing or prematurity status on supplementation efficacy. CONCLUSIONS: LCPUFA supplementation of infant formulas failed to show any significant effect on improving early infant cognition. Further research is needed to determine if LCPUFA supplementation of infant formula has benefits for later cognitive development or other measures of neurodevelopment.
BACKGROUND AND OBJECTIVE:Infant formula is supplemented with long-chain polyunsaturated fatty acids (LCPUFAs) because they are hypothesized to improve cognition. Several randomized controlled clinical trials have examined the effect of LCPUFA supplementation of infant formula on cognitive development. We conducted this meta-analysis to examine the efficacy of LCPUFA supplementation of infant formula on early cognitive development. METHODS: Two authors searched PubMed, PsychInfo, and Scopus for randomized controlled clinical trials assessing the efficacy of LCPUFA supplementation of infant formulas on cognition. Our analysis was restricted to randomized controlled clinical trials that examined the effect of LCPUFA supplementation on infant cognition using Bayley Scales of Infant Development. Our primary outcome was the weighted mean difference in Bayley Scales of Infant Development score between infants fed formula supplemented with LCPUFA compared with unsupplemented formula. We conducted secondary subgroup analyses and meta-regression to examine the effects of study sample, LCPUFA dose, and trial methodologic quality on measured efficacy of supplementation. RESULTS: Twelve trials involving 1802 infants met our inclusion criteria. Our meta-analysis demonstrated no significant effect of LCPUFA supplementation of formula on infant cognition. There was no significant heterogeneity or publication bias between trials. Secondary analysis failed to show any significant effect of LCPUFA dosing or prematurity status on supplementation efficacy. CONCLUSIONS: LCPUFA supplementation of infant formulas failed to show any significant effect on improving early infant cognition. Further research is needed to determine if LCPUFA supplementation of infant formula has benefits for later cognitive development or other measures of neurodevelopment.
Authors: D L O'Connor; R Hall; D Adamkin; N Auestad; M Castillo; W E Connor; S L Connor; K Fitzgerald; S Groh-Wargo; E E Hartmann; J Jacobs; J Janowsky; A Lucas; D Margeson; P Mena; M Neuringer; M Nesin; L Singer; T Stephenson; J Szabo; V Zemon Journal: Pediatrics Date: 2001-08 Impact factor: 7.124
Authors: N Auestad; R Halter; R T Hall; M Blatter; M L Bogle; W Burks; J R Erickson; K M Fitzgerald; V Dobson; S M Innis; L T Singer; M B Montalto; J R Jacobs; W Qiu; M H Bornstein Journal: Pediatrics Date: 2001-08 Impact factor: 7.124
Authors: Pilyoung Kim; Ruth Feldman; Linda C Mayes; Virginia Eicher; Nancy Thompson; James F Leckman; James E Swain Journal: J Child Psychol Psychiatry Date: 2011-04-18 Impact factor: 8.982
Authors: Dennis R Hoffman; Julia A Boettcher; Deborah A Diersen-Schade Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2009-06-07 Impact factor: 4.006
Authors: Peter Rzehak; Carel Thijs; Marie Standl; Monique Mommers; Claudia Glaser; Eugène Jansen; Norman Klopp; Gerard H Koppelman; Paula Singmann; Dirkje S Postma; Stefanie Sausenthaler; Pieter C Dagnelie; Piet A van den Brandt; Berthold Koletzko; Joachim Heinrich Journal: PLoS One Date: 2010-10-11 Impact factor: 3.240
Authors: John Colombo; Susan E Carlson; Carol L Cheatham; D Jill Shaddy; Elizabeth H Kerling; Jocelynn M Thodosoff; Kathleen M Gustafson; Caitlin Brez Journal: Am J Clin Nutr Date: 2013-06-26 Impact factor: 7.045